Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FACTIVE Outpatients Respiratory Infection Community Experience

Trial Profile

FACTIVE Outpatients Respiratory Infection Community Experience

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2007

At a glance

  • Drugs Amoxicillin/clavulanic acid; Clarithromycin; Gemifloxacin
  • Indications Acute exacerbations of chronic bronchitis; Bacterial infections; Community-acquired pneumonia
  • Focus Therapeutic Use
  • Acronyms FORCE
  • Sponsors Oscient Pharmaceuticals
  • Most Recent Events

    • 31 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top